Loading Episode...
The Accad and Koka Report - Michel Accad and Anish Koka 3rd May 2020
Ep. 123 Andrew Althouse on Clinical Trial Design and Remdesivir
00:00:00 01:01:55

Ep. 123 Andrew Althouse on Clinical Trial Design and Remdesivir

Our guest is Andrew Althouse, statistician at the Center for Clinical Trials and Data coordination in Pittsburgh. He holds an undergraduate degree in Statistics and a PhD in Epidemiology from the University of Pittsburgh. His main area of interest is the design of randomized control trials. He discusses adaptive randomized control trials, and dissects the recent news of the positive Remdesivir trial.

GUEST:

Andrew Althouse: Twitter and professional page

WATCH ON YOUTUBE:

Watch the episode on our YouTube channel

SUPPORT THE SHOW

Make a small donation on our Patreon page on and join our discussion group or receive a free book.